We would love to hear your thoughts about our site and services, please take our survey here.
All biotech , the entire sector, is down close to 40% for the last 12 months. It was a stat I was shocked to see but think it’s a sector issue that has sentiment issues in addition to our own company’s sentiment issues. Testing is just going to keep growing and expanding globally. There are 8 B people and eventually, everyone will get it, think they have it, vaxed or not. This is a sell the minute a cure is announced and no sign of that on the horizon.
With Pfizer’s efficacy only being 42% after 6 months according to John Hopkins study, and Moderna’ only 74% efficacious after 6 months, you can bet your farm that testing is the only avenue to know when to revax a booster or not fly, or not attend an event or ……the list goes on and on.
Please tell me Innova is on this list!!!
If you follow the Gillette principle, sell and place the razors in order to recurring-ly sell the blades. Sell and place the Q Machines to recurring-ly sell the test kits. That’s a real estate investment I’m hoping for while another 4 billion people have not even had their first vax and 4 billion more will need to get a booster, and only 200 million cases recorded to date. It’s just getting started.
There are 8 B people in the world. There are a total of 220M cases reported to date. 4B vaccines have been jabbed and we just found out have to be jabbed again, and most likely again and possibly again as CoVid continues to get a big head start over Vax’s and vax’s are proving to be ineffective in just 6 months per Israeli data, testing will continue I believe well beyond half life timing GM shared during the meeting, and Innova will continue to fail as a reliable testing platform. Accuracy will become the greater more ever pressing need to really slow the spread. And anti-mask sentiment will continue to grow- see France. I have never heard of an “anti-tester”. I think we are well within porky’s optimism and Soder’s pragmatism with a class PE ratio that is waiting to launch on the next sustainable indicator from the company and gaining a greater, still infantile, following in the US. Many reasons for optimism after this weeks call.
All of this sentiment has changed and guess how many of the articles Porky provided about the news on Nova that were picked up in the US? NODDA! ZERO! Nothing. E*TRADE is my platform and not one story carried over . AND GM said their quantity of communications was an indicator of quality of communications.
In America we call it a class action lawsuit where effected parties join forces to what appears to be a DHSC that has some kind of agenda.
Meanwhile, Innova from China via California, sells millions, appears to be paid on time, and deliver disastrous testing results based on percentages in sensitivity and accuracy and it’s resulting spread of the virus due to bad information it provides from TA tests with false positives , which are probably the reasons the US FDA did not give its approval. The DHS defends its support of this test and buys more? Unreal.
Was there any billing disputes reported with Innova? We’re they held accountable for the pathetic percentages for sensitivity and specificity? The US FDA kicked them out and threw them away and they are still being defended by the UK govt? Bribery or incompetence?
This story was the one I envisioned when I invested in NCYT, only with our test results and accuracy tied to INNOVAS clearly ill gotten revenues. This is mind boggling at its highest ethical standard. How the UK govt could give this consonant with a very shallow resume for what was needed to save lives and return the economy—-what the hell were they looking at other than cheap , cheap, cheap? They got their money’s worth that is for sure.
Just think of the C-19 state the UK would be in right now if every test done by Innova was a test done by Novacyt. The self quarantine, the affirmed positives, the REAL shut down that would have occurred in stopping the spread? How many more lives would have been spared —- a very real and true linkage here to that essential question. What a failure in leadership by the UK govt.
Wall Street Journal—- https://www.wsj.com/articles/the-science-suggests-a-wuhan-lab-leak-11622995184?st=8n3irb004h2nztp&reflink=article_copyURL_share
https://www.stokesentinel.co.uk/news/stoke-on-trent-news/mum-records-20-positive-lateral-5410336
COVID-19 variants will soon outnumber original strain, Fauci says
Read in CBS News: https://apple.news/AC-zL24L7TGKlKziIZSiV5g
How many vaccines will be needed? How many tests required ?
If you have read the book, The Great Influenza , and you are in or dabbled with this stock, read that book and you will know that this investment is for the long term and will be front and center for a long time. Historical perspective will be extremely helpful to your evaluations of the global challenge.
Mandy just confirmed 2020 will be announced before end of Jan. no day given.
Mapper, a slight difference from year to year could be revenues in 2019 of a little under $8M and revenues a year later north of $250M.
Poidster, my deepest sympathy and a tragic result to a very unfortunate risk we are all seeing lived out every day. Prayers for your friend and those kids.
Porky, tremendous and heartfelt response as well. It is bitter sweet in the truest sense what we, As investors, and to some extent depending on your loved ones, as victims of this horrifying and growing pandemic. I’m glad our common bond here is both as I think our company has had an amazing roll in saving lives that would not have been possible otherwise.
The new B.1.1.7 is a ‘super-spreader’ strain. Here’s how the U.S. can control it, says Dr. Eric Topol
Of all the news coming out about the virus that has wreaked havoc on our lives for the last year, the emergence of several possibly more infectious variants in different parts of the world is worrying.
Read in MarketWatch: https://apple.news/AjMhQM2ePRJC8xDzXFpwb_w
Shared from Apple News
We are on the American OTC CURRENTLY AND average less than 400 shares in volume a day. Very very smitten of volume. So yes, moving up to the NASDAQ would have the same effect as moving off of AIM and into midCap exchange with greater II coverage, exposure, huge PR boost, and more sellers means more rapid price changes.